X4 Pharmaceuticals Company
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Technology:
Data-driven Technologies
Funding Status:
IPO
Investor Type:
IPO
Investors Number:
12
Employee Number:
51-100
Last Funding Date:
2021
Headquarters:
Cambridge, Massachusetts, United States
Last Funding Type:
Post-IPO Equity
Total Funding:
119499999
Founded Date:
2014
Industry:
Biotechnology, Clinical Trials, Health Care, Pharmaceutical, Therapeutics
Estimated Revenue:
Less than $1M